Anthony Dudzinski

Anthony Dudzinski has a diverse work experience. Anthony served as the COO of American CryoStem starting in 2008. In this role, they were responsible for the collection, processing, and storage of adipose tissue and stem cells for future use in cosmetic surgery and cellular treatments. Anthony also oversaw the product division, ACS Laboratories, which offered laboratory and cellular growth media.

Prior to joining American CryoStem, Dudzinski was the President of XShares Securities LLC from 2007 to 2008. Anthony then moved on to become the CEO of XShares Advisors LLC from 2006 to 2008. In this role, they developed and managed 31 Exchange Traded Funds (ETFs) listed on the NYSE, including the TDX Target Dated Funds launched for TD Ameritrade.

Before their tenure at XShares Advisors, Dudzinski served as the President/Chief Operating Officer of XShares Group LLC from 2006 to 2008. In this position, they played a crucial role in the strategic management and day-to-day operations of the company.

Overall, Dudzinski's work experience showcases their leadership and expertise in various industries, including stem cell preservation, financial securities, and investment advisory services.

Anthony Dudzinski attended Baruch College from 1981 to 1983, studying Finance/Economics.